I-Corps: Early-stage cancer diagnostic platform using cell-free expression systems and lip — NSF Award to University of Minnesota-
The broader impact/commercial potential of this I-Corps project is the development of an early-stage cancer diagnostic to improve detection of cancer. In the US, 1.9 million people are diagnosed with cancer annually, with an average of 609,000 deaths. Currently, the healthcare reimbursement system mostly relies on pati
| Award title | I-Corps: Early-stage cancer diagnostic platform using cell-free expression systems and lip |
|---|---|
| Award ID | 2336583 |
| Awardee | University of Minnesota-Twin Cities |
| City | MINNEAPOLIS |
| State | MN |
| Amount obligated | $50,000 |
| Principal investigator | Kate Adamala |
| Program | ['01002324RB NSF RESEARCH & RELATED ACTIVIT'] |
| Start date | 09/01/2023 |
| Abstract | The broader impact/commercial potential of this I-Corps project is the development of an early-stage cancer diagnostic to improve detection of cancer. In the US, 1.9 million people are diagnosed with cancer annually, with an average of 609,000 deaths. Currently, the healthcare reimbursement system mostly relies on patients presenting symptoms, except for cancers of the breast or colon where there is proactive screening. However, detecting cancer early is critical to improving quality of life, de |
| Source | NSF Awards |
$799/mo
Try NSFGrants →